Compliance

We are committed to upholding the highest principles and ethics in the service of our patients.

Our standards are unwavering, which is why we strive to achieve 100% compliance in everything we do. We conduct our business with an unyielding commitment to uphold the highest principles and ethics. We do this for ourselves and for the patients we serve. 

California Act Declaration

Pharmacyclics’ ethics and compliance program (the “Program”) reflects our commitment to compliance with the laws and regulations applicable to our business, including the California Health and Safety Code §§119400-119402 (the “California Act”). Interested parties may view the Program online or may also call 1-800-254-0462 for a copy of any of the Program materials.

In accordance with the California Act, Pharmacyclics has established a specific annual dollar limit of $2,500, which applies to promotional materials, items, and activities provided by an employee of Pharmacyclics businesses to covered recipients in California. In addition, the following expenses are excluded from the limit: expenses of a de minimis value (i.e., with a value of $10 or less), expenses that are directly associated with payments statutorily excluded from the limit (e.g., meals for consultants), items provided to health care professionals that are ultimately intended for patients or consumers, fellowships, receptions at third party educational or professional meetings, and sales aids. To the best of its knowledge, Pharmacyclics declares that as of March 20, 2020, it is in all material respects in compliance with our Program and the requirements of the California Act.

Open Payments—Physician Payments Sunshine Act

The US Sunshine Act, also known as the Open Payments—Physician Payments Sunshine Act, was enacted as federal law in 2010 as a component of the Affordable Care Act. The Act requires health care manufacturers, including AbbVie, to track financial transactions with certain health care providers (HCPs) and health care organizations (HCOs) and to disclose those transactions on an annual basis. We support the Act and its goal of providing the public greater visibility into interactions between the health care industry and HCPs to ensure public trust and confidence.

U.S. Centers for Medicare and Medicaid Services (CMS) Open Payments Website

Pharmacyclics, an AbbVie Company, provides a list of grants and contributions below.

Additional grants and contributions disclosures for support paid separately by AbbVie, our Parent Company, is available here.

Grants & Contributions Reports
2019
2018
2017
2016
2015